We have data on 100 companies that use IBM Clinical Development. The companies using IBM Clinical Development are most often found in United States and in the Pharmaceuticals industry. IBM Clinical Development is most often used by companies with >10000 employees and >1000M dollars in revenue. Our data for IBM Clinical Development usage goes back as far as 2 years and 3 months.
|Company||Merge Healthcare Incorporated|
|Company||University of Pittsburgh|
|Merge Healthcare Incorporated||merge.com||United States||100M-200M||1000-5000|
|Advanced Clinical||advancedclinical.com||United States||50M-100M||500-1000|
|Duke University||duke.edu||United States||>1000M||>10000|
|University of Pittsburgh||pitt.edu||United States||10M-50M||>10000|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, IBM Clinical Development has a market share of about 0.1%. Other major and competing products in this category include:
IBM Clinical Development is a unified cloud-based EDC (Electronic Data Capture) platform designed to reduce the time and cost of clinical trials and enable life sciences organizations to bring therapies faster to their patients. It allows to gather, organize, analyze and report data for any type, size or phase of trial anywhere in the world.
Looking at IBM Clinical Development customers by industry, we find that Pharmaceuticals (29%), Research (19%), Hospital & Health Care (14%), Higher Education (8%) and Biotechnology (6%) are the largest segments.
71% of IBM Clinical Development customers are in United States and 6% are in Canada.
Of all the customers that are using IBM Clinical Development, a majority (57%) are large (>1000 employees), 4% are small (<50 employees) and 28% are medium-sized.
Of all the customers that are using IBM Clinical Development, 42% are small (<$50M), 0% are medium-sized and 39% are large (>$1000M).